Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
NCT: NCT07462507 · RECRUITING
Brief Summary
Adult patients with primary or secondary central nervous system malignancies will be invited to undergo a baseline \[C-11\]-CS1P1 PET scan and a follow-up scan within 24 months of the baseline scan (preferably within 6-months post-treatment).The study will describe patterns of tracer uptake in tumors and normal brain and explore how these patterns relate to MRI findings, treatments received, and clinical outcomes.
Frequently Asked Questions
What is Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1?
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 is a clinical trial registered under NCT07462507. Current status: RECRUITING.
What is the status of NCT07462507?
The current status of NCT07462507 (Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1) is: RECRUITING.
When did Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 start?
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1 started on 2026-04-16.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.